Trisura Investor Presentation – May 2022
A Growing Specialty Insurer
A Growing Specialty Insurer
-
•Canadian specialty lines franchise operating for 16 years
-
•US hybrid fronting platform participating in the admitted and non-admitted ('E&S') markets
-
•Earnings supported by an attractive mix of underwriting income and fee-based and investment income
-
•Conservative debt-to-capital1of 17.4% and capital in excess of regulatory requirements in subsidiaries
-
•Issuer rating of BBB (DBRS); Financial Strength ratings of A (low) (DBRS) and A- (AM Best) at operating subsidiaries
-
•Consistent profitability: 19% consolidated LTM Q1/22 ROE1; 5-year average 86% combined ratio1,2in
Canada and 30% LTM Q1/22 ROE; increasing profitability from US subsidiary reaching a 14% LTM Q1/22 ROE -
•Conservative approach to reserving; consistent history of favourable prior year claims development
-
•5-year GPW CAGR of 66%2(35%2, 3in
Canada , 165%2, 3CAGR in US) -
•Growth supported by expanding distribution relationships in existing lines of business and growth of our fronting model in
Canada and US -
•Proven access to capital (raised
$126 million in equity &$75 million in debt) and reinsurance relationships to support growth
-
•High quality investment portfolio comprised primarily of cash (34%), government bonds (7%), and corporate fixed income(35%)
-
•Conservative underwriting culture; limited retention in US and 5-year average loss ratio of 23%1,2in
Canada -
•Disciplined reinsurance strategy; deep relationships with high-quality counterparties
-
•Strong enterprise risk management infrastructure in place
-
•Management team with a diversity of skills, and strong relationships with regulators and distribution partners; senior management directly owns ~6% of shares outstanding
-
•Board of Directors comprised of seasoned executives with strong experience across financial services
Specialty Insurer Targeting Mid-teens ROEs and Growth in Book Value
Note: All figures in C$ million unless otherwise stated.
1This is a supplementary financial measure. Refer to Q1 2022 MD&A, Section 10, Operating Metrics table for its composition. To access MD&A, see
-
2As of
December 31 st, 2021. -
35-year CAGR in
Canada , 3-year CAGR in US
Company Overview
-
•
Trisura Group Ltd. (TSX: TSU) is a specialty insurer operating in the surety, risk solutions, corporate insurance and fronting market segments -
•
Trisura operates in niche segments, relying on focused underwriting knowledge and structuring expertise to offer commercial products and services not provided by most insurers -
•Components of
Trisura were founded and incubated withinBrookfield Asset Management ; Canadian specialty insurance in 2006 and US fronting in 2017 prior to spin-out -
Canada US
-
•16-year operating history in surety, risk solutions and corporate insurance segments; strong track record of profitable underwriting
-
•LTM Q1/22 GPW:
$618 million -
•LTM Q1/22 Net Income:
$44 million , 30% ROE -
•DBRS Rating: A (Low)
-
•A.M. Best Rating: A- (Excellent) Size 9
Key Performance Metrics
-
•Hybrid fronting business that works with distribution partners and cedesmajority of risk to reinsurance markets
-
•LTM Q1/22 GPW:
$1.1 billion -
•LTM Q1/22 Net Income:
$27 million , 14% ROE -
•DBRS Rating: A (Low)
-
•A.M. Best Rating: A- (Excellent) Size 9
+59% Since
+16% Y/Y
+63% Y/Y
+48% Y/Y
Note: All figures in C$ million unless otherwise stated.1As at
Key Achievements
Share Price Performance1and GPW Growth($ millions)
Key Achievements
✓✓✓ ✓ ✓ ✓ ✓ ✓
June -
May -
June -
January -
Note: All figures in C$ million unless otherwise stated.
-
1Cumulative share price performance measured from close of business
December 31 st, 2017. -
2'Current' as at
May 6 th, 2022.
Strategic Priorities
-
•Expand North American insurance market share through enhanced distribution and capacity relationships
-
•Build fronting model of scale in US and Canadian markets
Growth
-
•Grow Admitted business and obtain
US Treasury listing -
•Evaluate strategic partnerships and inorganic growth
-
•Demonstrate the value of specialty focus through strong loss ratio and underwriting margin outperformance
-
•Leverage fixed cost base and technology to gain scale, demonstrating sustainable mid-teens ROE
-
•Diversify earnings to produce stable returns
-
•Maintain and improve ratings and appropriate regulatory capital
-
•Synchronize risk management across the platform
-
•Optimize capital allocation, reflecting appropriate capitalization for insurance, credit and market risks
-
•Enhance yield and increase allocation to alternatives; maintain appropriate risk profile and improve diversification
-
•Develop track record of execution, expand shareholder base and distribution partners
-
•Strengthen access to capital and enhance ability to fund growth
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer


BM TECHNOLOGIES, INC. – 10-K – MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
INVESTORS TITLE CO – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations
Advisor News
- Can your advisory firm survive without you?
- I started using AI, but what now?
- How to support an entrepreneur client with multiple businesses
- Could a narrower focus help grow your practice?
- U.S. debt hits $40 trillion: how to support concerned clients
More Advisor NewsAnnuity News
- Solen Software Group Acquires Cooperative Technologies, Provider of 1035 Exchange and Annuity Replacement Software
- MassMutual Expands Lending Options With New Secured Credit Line
- Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
- Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
- IMOs get frustrated with slow carrier adoption of faster technology
More Annuity NewsHealth/Employee Benefits News
- Researchers from Department of Research and Innovation Report on Findings in Managed Care (Quantifying Medicare prescription payment plan benefits under Medicare Part D): Managed Care
- New Managed Care Study Results from Brigham and Women’s Hospital and Harvard University Described (Supplemental Rebates From Drug Makers To State Medicaid Programs Grew Fivefold From 2017 To 2024): Managed Care
- Nebraska SHIP offers support during Medicare open enrollment
- Patients demand access to prescription drugs but need support
- Oscar Health Inc. (NYSE: OSCR) Makes an Unexpected Move During Monday’s Session
More Health/Employee Benefits NewsLife Insurance News